-
Product Name
Cynomolgus ICOSLG recombinant protein (C-human IgG1-Fc)
- Documents
-
Description
Inducible co-stimulator ligand (ICOSL), also known as B7-H2, is a member of the B7 family of co-stimulatory molecules related to B7-1 and B7-2. It is a transmembrane glycoprotein with extracellular IgV and IgC domains, and binds to ICOS on activated T cells, thus delivers a positive costimulatory signal for optimal T cell function. The structural features of ICOSL are crucial for its costimulatory function. Present study shows that ICOSL displays a marked oligomerization potential, resembling more like B7-1 than B7-2. B7-H2-dependent signaling may play an active role in a proliferative response rather than in cytokine and chemokine production. The CD28/B7 and ICOS/B7-H2 pathways are both critical for costimulating T cell immune responses. Deficiency in either pathway results in defective T cell activation, cytokine production and germinal center formation.Immune Checkpoint
Immune Checkpoint Detection: Antibodies Immune Checkpoint Detection: ELISA Antibodies Immune Checkpoint Detection: FCM Antibodies Immune Checkpoint Detection: WB Antibodies
Immune Checkpoint Targets Co-stimulatory Immune Checkpoint Targets Immunotherapy Cancer Immunotherapy Targeted Therapy -
Uniprot ID
A0A1D5Q2R9
-
Source/Expression Host
Human Cells
-
Expression Plasmid/cDNA
A DNA sequence encoding the cynomolgus ICOSLG (XP_005548617.1) (Met1-Thr256) was expressed with the Fc region of human IgG1 at the C-terminus.
-
Protein Species
Cynomolgus
-
Molecular weight
The recombinant cynomolgus ICOSLG consists of 476 amino acids and predicts a molecular mass of 53.3 kDa.
-
Purity
> 95 % as determined by SDS-PAGE.
-
Validations
Cynomolgus ICOSL/ICOS ligand/B7-h2 Protein 14495
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"